Surface levels of TIGIT were significantly lower on both inflamed mucosal CD4+ and CD8+ T cells of active IBD patients than that of the non-inflamed mucosa samples from remitting patients or the control samples (12). This evidence concerns the gene TIGIT and inflammatory bowel disease.